Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COVID-19 Pandemic Means Another Delay For Canadian Pricing Reforms

Jan 11 2022

• By Francesca Bruce

Covid-19 in Canada — COVID-19 • Source: Alamy

Related Content

Canadian Drug Pricing Reforms Could Lead To Medicine Shortages

Aug 20 2019

COVID-19 Causes Further Delay To Canada’s Controversial Pricing Reforms

Jun 30 2021

Additional Topics

Canada Coronavirus COVID-19 Health Technology Assessment Market Access Policy Pricing Debate Regulation BioPharmaceutical

More from Canada

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window